Increasing the Therapeutic Ratio of Radiotherapy

Current cancer therapies are focused on three general strategies: modifying intrinsic radiosensitivity via molecular targeting, manipulating microenvironmental factors to enhance tumor susceptibility to radiation, and improving delivery of radiation to critical tumor locations while sparing normal t...

Full description

Saved in:
Bibliographic Details
Other Authors: Tofilon, Philip J (Editor)
Camphausen, Kevin (Editor)
Corporate Authors: SpringerLink (online služba)
Format: eBook
Language:English
Published: Cham : Springer International Publishing , 2017
Series:Cancer Drug Discovery and Development
Genre/form:elektronické knihy
ISBN:978-3-319-40854-5
9783319408521
Subjects:
Online Access:Full-text
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04322nam a22004815i 4500
001 001823709
003 CZ PrSTK
005 20170816142203.0
006 m f d
007 cr nn 008mamaa
008 161121s2017 gw | s |||| 0|eng d
020 |a 978-3-319-40854-5  |9 9783319408545 
024 7 |a 10.1007/978-3-319-40854-5  |2 doi 
040 |a DE-He213  |b cze  |d ABA013 
072 7 |a 57  |x Obecná biologie  |2 Konspekt  |9 2 
080 |a 57:61  |2 MRF 
245 1 0 |a Increasing the Therapeutic Ratio of Radiotherapy /  |c edited by Philip J. Tofilon, Kevin Camphausen 
264 1 |a Cham :  |b Springer International Publishing ,  |c 2017 
300 |a 1 online zdroj (VIII, 280 stran) :  |b 41 ilustrací, 34 barevných ilustrací 
336 |a text  |b txt  |2 rdacontent 
337 |a počítač  |b c  |2 rdamedia 
338 |a online zdroj  |b cr  |2 rdacarrier 
490 1 |a Cancer Drug Discovery and Development,  |x 2196-9906 
505 0 |a Part 1. Molecular Targets -- 1. Improving the therapeutic ratio of radiotherapy by targeting the DNA Damage Response -- 2. Receptor Tyrosine Kinases as Targets for Enhancing Tumor Radiosensitivity -- 3. Histone Deacetylase Inhibitors and Tumor Radiosensitization -- 4. Radioprotection as a Method to Enhance the Therapeutic Ratio of Radiotherapy -- Part 2. Microenvironment -- 5. Application of Functional Molecular Imaging in Radiation Oncology -- 6. Remodeling the Irradiated Tumor Microenvironment: The 5th R of Radiobiology? -- 7. Combining Radiotherapy and Immunotherapy: Emerging Preclinical Observations of Lymphocyte Costimulatory and Inhibitory Receptor Modulation -- Part 3. Clinical -- 8. Stereotactic Body Radiation Therapy (SBRT) or Alternative Fractionation Schedules -- 9. Novel Imaging for Treatment Planning or Tumor Response -- 10. Increasing the Therapeutic Efficacy of Radiotherapy Using Nanoparticles -- Index 
520 |a Current cancer therapies are focused on three general strategies: modifying intrinsic radiosensitivity via molecular targeting, manipulating microenvironmental factors to enhance tumor susceptibility to radiation, and improving delivery of radiation to critical tumor locations while sparing normal tissues. The goal of this volume is to describe a number of promising approaches corresponding to each strategy. In general, research in radiation oncology tends to be siloed into fundamental biology, physics or treatment delivery. The strategies for improving therapeutic ratio encompassed in this book will involve each of these components of radiation oncology. Thus, they will illustrate the variety of disparate approaches available for potentially improving the efficacy of radiotherapy, which may then stimulate discussion across disciplines and foster further translational investigations. Although a goal of each chapter will be to highlight advances within an approach, of equal importance will be the delineation of barriers to successful clinical application and how to overcome or minimize such impediments. Along these lines, because therapeutic ratio incorporates both tumor and normal tissue radio response, a point of emphasis will be the mechanistic rationale for selectively modifying tumor (sensitization) or normal cells (protection). Finally, whereas the literature is replete with studies describing potential targets/strategies for increasing the therapeutic ratio for radiotherapy, this book will focus on those supported by in vivo data consistent with impending translational application along with those that are already being evaluated in the clinic 
655 7 |a elektronické knihy  |7 fd186907  |2 czenas 
659 0 |a Medicine 
659 0 |a Cancer research 
659 0 |a Drug resistance 
659 0 |a Radiotherapy 
659 1 4 |a Biomedicine 
659 2 4 |a Cancer Research 
659 2 4 |a Radiotherapy 
659 2 4 |a Drug Resistance 
650 0 7 |a lékařství  |x zd  |7 psh12931  |2 psh 
650 0 7 |a radioterapie  |x zd  |7 psh12765  |2 psh 
710 2 |a SpringerLink (online služba)  |7 ntk2018999494 
700 1 |a Tofilon, Philip J  |4 edt 
700 1 |a Camphausen, Kevin  |4 edt 
776 0 8 |i Tištěné vydání:  |t Increasing the Therapeutic Ratio of Radiotherapy  |z 9783319408521 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-40854-5  |y Plný text 
830 0 |a Cancer Drug Discovery and Development 
950 |a Springer  |b Medicine 2017